摘要
肺癌是全球最常见的恶性肿瘤之一,发病率和死亡率呈逐年上升趋势。提高肺癌患者生存率的关键在于早发现,早诊断,早治疗。大量证据表明甲状腺功能的改变与恶性肿瘤,特别是乳腺癌之间存在相互作用关系。然而,甲状腺功能与肺癌是否有相关性,目前研究未明确,有关文献报道,许多非甲状腺疾病患者,特别是一些恶性肿瘤患者,其甲状腺激素(Thyroid hormone, TH)水平可能会发生变化。本文结合国内外相关研究进展,对非小细胞肺癌(non-small cell lung cancer, NSCLC)患者与甲状腺激素水平的相关性做一综述,为临床评估NSCLC患者的病情及临床预后提供参考。
Lung cancer is one of the most common malignant tumors in the world. Morbidity and mortality are on the rise year by year. The key to improve the survival rate of lung cancer patients is early detection, early diagnosis and early treatment. In recent years, a large number of indirect evidences have shown that there is an interaction between thyroid function and malignant diseases, especially breast carcinoma. However, the association between thyroid function and lung cancer has only been reported occasionally. It has been reported in the literature that the level of Thyroid hormone (TH) may change in many patients with non-thyroid diseases, especially in some patients with malignant tumors. Thyroid hormone may play a role in diseases other than hyperthyroidism and hypothyroidism. This article reviews the correlation between thyroid hormone levels and non-small cell lung cancer (NSCLC) patients, in order to provide reference for clinical evaluation of the condition and prognosis of NSCLC patients, and to guide clinical treatment.
出处
《临床医学进展》
2020年第3期191-196,共6页
Advances in Clinical Medicine
